Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name
Market Cap
Price to Earnings
TTM
Dividend Yield
% TTM
us flag iconSGENSeagen$43.15bnn/an/a
us flag iconINSMInsmed$29.32bnn/an/a
us flag iconIQVIqvia Holdings$27.88bn19.82n/a
us flag iconBNTXBioNTech SE$22.44bnn/an/a
us flag iconEXASExact Sciences$20.03bnn/an/a
us flag iconRVMDRevolution Medicines$18.98bnn/an/a
us flag iconASNDAscendis Pharma A/S$13.75bnn/an/a
us flag iconRGCRegencell Bioscience Holdings$13.53bnn/an/a
us flag iconMEDPMedpace Holdings$12.84bn29.62n/a
us flag iconKRTXKaruna Therapeutics$12.58bnn/an/a
us flag iconSMMTSummit Therapeutics$12.03bnn/an/a
us flag iconIONSIonis Pharmaceuticals$11.73bnn/an/a
us flag iconEXELExelixis$10.72bn14.55n/a
us flag iconMDGLMadrigal Pharmaceuticals$10.12bnn/an/a
us flag iconRXDXPrometheus Biosciences$9.56bnn/an/a
us flag iconIMGNImmunoGen$8.72bnn/an/a
us flag iconIBRXImmunitybio$8.71bnn/an/a
us flag iconTEMTempus AI$8.40bnn/an/a
us flag iconBPMCBlueprint Medicines$8.37bnn/an/a
us flag iconPRAXPraxis Precision Medicines$8.31bnn/an/a